» Articles » PMID: 29451534

Simple Decision-tree Tool to Facilitate Author Identification of Reporting Guidelines During Submission: a Before-after Study

Overview
Publisher Biomed Central
Date 2018 Feb 17
PMID 29451534
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

Background: There is evidence that direct journal endorsement of reporting guidelines can lead to important improvements in the quality and reliability of the published research. However, over the last 20 years, there has been a proliferation of reporting guidelines for different study designs, making it impractical for a journal to explicitly endorse them all. The objective of this study was to investigate whether a decision tree tool made available during the submission process facilitates author identification of the relevant reporting guideline.

Methods: This was a prospective 14-week before-after study across four speciality medical research journals. During the submission process, authors were prompted to follow the relevant reporting guideline from the EQUATOR Network and asked to confirm that they followed the guideline ('before'). After 7 weeks, this prompt was updated to include a direct link to the decision-tree tool and an additional prompt for those authors who stated that 'no guidelines were applicable' ('after'). For each article submitted, the authors' response, what guideline they followed (if any) and what reporting guideline they should have followed (including none relevant) were recorded.

Results: Overall, 590 manuscripts were included in this analysis-300 in the before cohort and 290 in the after. There were relevant reporting guidelines for 75% of manuscripts in each group; STROBE was the most commonly applicable reporting guideline, relevant for 35% ( = 106) and 37% ( = 106) of manuscripts, respectively. Use of the tool was associated with an 8.4% improvement in the number of authors correctly identifying the relevant reporting guideline for their study ( < 0.0001), a 14% reduction in the number of authors incorrectly stating that there were no relevant reporting guidelines ( < 0.0001), and a 1.7% reduction in authors choosing a guideline ( = 0.10). However, the 'after' cohort also saw a significant increase in the number of authors stating that there were relevant reporting guidelines for their study, but not specifying which (34 vs 29%;  = 0.04).

Conclusion: This study suggests that use of a decision-tree tool during submission of a manuscript is associated with improved author identification of the relevant reporting guidelines for their study type; however, the majority of authors still failed to correctly identify the relevant guidelines.

Citing Articles

Endorsements of five reporting guidelines for biomedical research by journals of prominent publishers.

Wang P, Wolfram D, Gilbert E PLoS One. 2024; 19(2):e0299806.

PMID: 38421981 PMC: 10903802. DOI: 10.1371/journal.pone.0299806.


Reproducibility and Scientific Integrity of Big Data Research in Urban Public Health and Digital Epidemiology: A Call to Action.

Quiroga Gutierrez A, Lindegger D, Taji Heravi A, Stojanov T, Sykora M, Elayan S Int J Environ Res Public Health. 2023; 20(2).

PMID: 36674225 PMC: 9861515. DOI: 10.3390/ijerph20021473.


Interstitial I Brachytherapy as a Salvage Treatment for Refractory Cervical Lymph Node Metastasis of Thoracic Esophageal Squamous Cell Carcinoma After External Irradiation With a CT-Guided Coplanar Template-Assisted Technique: A Retrospective Study.

Li P, Fan J, Zhang K, Wang J, Hu M, Yang S Technol Cancer Res Treat. 2022; 21:15330338221103102.

PMID: 35656785 PMC: 9168871. DOI: 10.1177/15330338221103102.


What we are doing to help researchers publish their papers in our journal.

Mallarkey G, Thorne M J Int Med Res. 2022; 50(5):3000605221100927.

PMID: 35578998 PMC: 9130814. DOI: 10.1177/03000605221100927.


Writing up your clinical trial report for a scientific journal: the REPORT trial guide for effective and transparent research reporting without spin.

Bandholm T, Thorborg K, Ardern C, Christensen R, Henriksen M Br J Sports Med. 2022; 56(12):683-691.

PMID: 35193854 PMC: 9163716. DOI: 10.1136/bjsports-2021-105058.


References
1.
Fontela P, Pai N, Schiller I, Dendukuri N, Ramsay A, Pai M . Quality and reporting of diagnostic accuracy studies in TB, HIV and malaria: evaluation using QUADAS and STARD standards. PLoS One. 2009; 4(11):e7753. PMC: 2771907. DOI: 10.1371/journal.pone.0007753. View

2.
Glasziou P, Altman D, Bossuyt P, Boutron I, Clarke M, Julious S . Reducing waste from incomplete or unusable reports of biomedical research. Lancet. 2014; 383(9913):267-76. DOI: 10.1016/S0140-6736(13)62228-X. View

3.
Hoffmann T, Thomas S, Shin P, Glasziou P . Cross-sectional analysis of the reporting of continuous outcome measures and clinical significance of results in randomized trials of non-pharmacological interventions. Trials. 2014; 15:362. PMC: 4177425. DOI: 10.1186/1745-6215-15-362. View

4.
Bossuyt P, Reitsma J, Bruns D, Gatsonis C, Glasziou P, Irwig L . Towards complete and accurate reporting of studies of diagnostic accuracy: the STARD initiative. BMJ. 2003; 326(7379):41-4. PMC: 1124931. DOI: 10.1136/bmj.326.7379.41. View

5.
McShane L, Altman D, Sauerbrei W, Taube S, Gion M, Clark G . REporting recommendations for tumour MARKer prognostic studies (REMARK). Br J Cancer. 2005; 93(4):387-91. PMC: 2361579. DOI: 10.1038/sj.bjc.6602678. View